Literature DB >> 525997

Rapid assay for determination of trimethoprim and sulfamethoxazole levels in serum by spectrofluorometry.

D M Lichtenwalner, B Suh, B Lorber, A M Sugar.   

Abstract

A rapid spectrofluorometric method for determining the levels of both trimethoprim and sulfamethoxazole from the same specimen of serum is described. The method involves stepwise extraction of the specimen first with chloroform at an alkaline pH (pH 9.0) for trimethoprim followed by n-butyl chloride at an acidic pH (pH 2.0) for sulfamethoxazole. To quantitate trimethoprim, the chloroform layer was subjected to fluorometry by exciting the specimen at 295 nm and measuring the relative intensity at 330 nm. To determine sulfamethoxazole levels, the n-butyl chloride layer was subjected to fluorometry by exciting the specimen at 285 nm and measuring the relative intensity at 330 nm. Relative intensities were linear (r greater than 0.99) over the concentration ranges of 0.5 to 40 microgram/ml for trimethoprim and 1 to 400 microgram/ml for sulfamethoxazole. Values obtained by this spectrofluorometric procedure were in excellent agreement with those obtained by a conventional fluorometric assay for trimethoprim and a colorimetric assay for sulfamethoxazole. Elevated levels of endogenous metabolic products and numerous other drugs, including a number of antimicrobial agents, did not interfere with the method. Although salicylates interfere with the determination of sulfamethoxazole, an appropriate correction can be made. This method can also be used to determine the drug levels in cerebrospinal fluid.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 525997      PMCID: PMC352908          DOI: 10.1128/AAC.16.5.579

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  Rapid determination of salicylate in biological fluids.

Authors:  P TRINDER
Journal:  Biochem J       Date:  1954-06       Impact factor: 3.857

Review 2.  Trimethoprim-sulfamethoxazole. I. Description.

Authors:  G P Wormser
Journal:  N Y State J Med       Date:  1978-10

3.  Measurement of triglycerides using nonane extraction and colorimetry.

Authors:  A L Levy
Journal:  Ann Clin Lab Sci       Date:  1972 Nov-Dec       Impact factor: 1.256

4.  New rapid assay for nafcillin in serum by spectrofluorometry.

Authors:  D M Lichtenwalner; B Suh; B Lorber; A M Sugar
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

5.  A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients.

Authors:  M J Gurwith; J L Brunton; B A Lank; G K Harding; A R Ronald
Journal:  Am J Med       Date:  1979-02       Impact factor: 4.965

6.  Successful chemoprophylaxis for Pneumocystis carinii pneumonitis.

Authors:  W T Hughes; S Kuhn; S Chaudhary; S Feldman; M Verzosa; R J Aur; C Pratt; S L George
Journal:  N Engl J Med       Date:  1977-12-29       Impact factor: 91.245

7.  Clinical pharmacology of intravenously administered trimethoprim-sulfamethoxazole.

Authors:  W E Grose; G P Bodey; T L Loo
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

  7 in total
  2 in total

1.  Radioenzymatic assay for trimethoprim in very small serum samples.

Authors:  R Yogev; C Melick; L Tan-Pong
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

2.  Distribution of trimethoprim and sulphamethoxazole in blood during treatment with co-trimoxazole.

Authors:  A Nowak; A Klimowicz; M Kadyków
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.